18 May 2007
Contrast-enhanced ultrasonography in diagnosing liver metastases
Jacek R. Janica, Urszula Łebkowska, Andrzej Ustymowicz, Albert Augustynowicz, Zbigniew Kamocki, Dorota Werel, Jerzy Polaków, Bogusław Kędra, Witold PepinskiMed Sci Monit 2007; 13(1): 111-115 :: ID: 482392
Abstract
Background: Dual-phase spiral computed tomography (CT) is still the primary imaging technique in the diagnosis of focal liver lesions. Contrast-enhanced ultrasonography (CEUS) is the most sensitive sonographic technique. The purpose of this study was to investigate the efficacy of CEUS in detecting liver metastases compared with CT as the standard of reference. Material and Methods: The examined group consisted of 51 patients (24 men and 27 women, age range: 27–84 years, mean: 57.4 years) suspected of liver metastases. The routine diagnostic approach consisted of B-mode US, CEUS, and CT. Final diagnosis was made at cytologic (n=18) or histologic examination (n=14) and in 9 patients by combining information from CT scans, medical history, and clinical and biochemical investigations.
Results: Liver cysts and abscesses were detected in 10 patients. They were excluded from the further analyses. In the remaining 41 patients a total of 134 metastases were detected. In 15 patients with metastases, US images of the liver appeared normal. CEUS detected metastases in 36 patients. The sensitivities of the methods per patient were US 63.4% and CEUS 90.2%. Sensitivities of the methods per lesion were US 60.9%, CT 77.6%, and CEUS 90.2%. Application of contrast media (SonoVue®) significantly increased diagnosing of liver metastases compared with standard sonography and CT. Conclusions: CEUS increased diagnostic confidence in the detection and characterization of hepatic metastases compared with standard sonography. Real-time contrast-enhanced sonography is particularly advantageous in detecting small metastases.
Keywords: Aged, 80 and over, Contrast Media - metabolism, Liver Neoplasms - ultrasonography, Tomography, Spiral Computed - methods
Editorial
01 March 2024 : Editorial
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-ThalassemiaDOI: 10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
In Press
18 Mar 2024 : Clinical Research
Sexual Dysfunction in Women After Tibial Fracture: A Retrospective Comparative StudyMed Sci Monit In Press; DOI: 10.12659/MSM.944136
21 Feb 2024 : Clinical Research
Potential Value of HSP90α in Prognosis of Triple-Negative Breast CancerMed Sci Monit In Press; DOI: 10.12659/MSM.943049
22 Feb 2024 : Review article
Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...Med Sci Monit In Press; DOI: 10.12659/MSM.943168
23 Feb 2024 : Clinical Research
A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...Med Sci Monit In Press; DOI: 10.12659/MSM.943732
Most Viewed Current Articles
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952